DexCom (DXCM) Misses Q3 EPS by 1c, Revenue Beats
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.53 --0%
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +9.9%
Financial Fact:
Net loss: -18.8M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $69 million versus the consensus estimate of $60.2 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- General Mills beats estimates as cost savings offset volumes
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
